|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results
DOI: 10.5501/wjv.v6.i4.59
Alyson Harty, Andrea D Branch, Charissa Y Chang, David Del Bello, Douglas T Dieterich, Gene Y Im, James F Crismale, Jennifer Leong, Joseph A Odin, Joshua Hartman, Keith M Sigel, Kian Bichoupan, Lawrence U Liu, Meena B Bansal, Michel Ng, Nancy Bach, Neal Patel, Neeta Tandon, Ponni V Perumalswami, Priya Grewal, Scott L Friedman, Sweta Chekuri, Thomas D Schiano
Keywords: Cirrhosis, Cost, Sustained virological response, Protease inhibitor, Polymerase inhibitor
Abstract:
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
